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There  is  good  evidence  that  B  cells  can  be  activated  by  several  distinct 
pathways.  The  intensity and isotype of the antibody response of a  subset of B 
cells  to  certain  antigens  (Type  2  T-independent  antigens)  is  determined  by 
nonspecific  factors  produced  by T  cells and  macrophages  (1-5).  A  different 
activation  pathway is required  for antibody responses to  low doses of soluble 
antigen (6).  This pathway has two cardinal  features.  First,  "classical" inducer T 
cells must be focused onto target B cells by a foreign protein containing a portion 
that covalently links the determinant seen by the T  inducer and B cells, forming 
a so-called "antigen bridge." Second, I-A region products on B cells must be the 
same as  those expressed on antigen-presenting  cells (APC) 1 that  first initiated 
clonal expansion of the inducer T  cell. These observations have given rise to the 
theory  that  activated  inducer  cells bearing  receptors  for a  particular  peptide 
associated with I-A gene products activate B cells that display I-A as well as the 
peptide  antigen  bound  to  the  B  cell  surface  immunoglobulin  (Ig)  receptors. 
However,  there  is  little  direct  evidence  to  support  this  hypothesis,  and  no 
evidence that recognition and activation may be mediated by a secreted form of 
the inducer cell surface receptor. 
In a previous report we described the derivation and the specificity of activation 
of a panel of hapten-reactive inducer T  cell clones. One group of clones, termed 
conjugate specific, is activated by hapten conjugated to the carrier protein used 
for in vitro selection and expansion. The second group, termed hapten specific, 
is activated by a particular hapten coupled to virtually all foreign and autologous 
proteins.  Both types of clones corecognize conventional  antigen  in association 
with products of the I-A locus (7). 
In this report,  we examine the biologic activity of molecules synthesized and 
secreted by these hapten-reactive  inducer clones. After stimulation  by antigen- 
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pulsed adherent cells or the  T  cell  mitogen concanavalin A  (Con  A), a  single 
inducer clone secretes both antigen-specific inducer peptides as well as nonspe- 
cific factors that activate B cells. The latter amplify the response of B  cells to 
Type 2 T-independent antigens and the in vitro response to sheep erythrocytes 
(SRBC). The former consist of antigen-binding molecules (ABM). ABM induce 
plaque-forming cell  (PFC)  responses  specific for a  determinant recognized by 
immune B cells, provided that cultures containing ABM and B cells are stimulated 
with antigen that links the epitope recognized by ABM with the B cell epitope. 
Induction of B cells by ABM is limited to B cells that express the same I-A allele 
as the source of the ABM and this H-2-restricted interaction between ABM and 
B  cells  reflects  binding  by  ABM  to  I-A  products  on  B  lymphocytes. Finally, 
analysis of the fine specificity of B cell activation by inducer molecules suggests 
that inducer T  cells can activate B  cells by secreting a  modified form of their 
cell-bound receptor. 
Materials and Methods 
Animals.  BALB/c, C57BL/6, C57BL/10, CB6F1, and B10.A(5R) mice were obtained 
from The Jackson Laboratory, Bar Harbor, ME. B10.A(3R) and B10.A(4R) mice were 
bred in the Michael Redstone Animal Facility of the Dana-Farber Cancer Institute from 
breeding pairs donated by Dr. D. Murphy, Yale University School of Medicine, and from 
Dr. D. Sachs, the National Institutes of Health. 
Antisera and Complement.  Monoclonal (mc) anti-Thy-l.2 was kindly donated by Dr. Ed 
Clark, University of Washington, Seattle, WA. Monoclonal antisera to Ly 1.2 and 2.2 
were obtained from Dr.  F. W. Shen, Memorial Sloan-Kettering Cancer Center. Rabbit 
complement was obtained from Pel-Freeze (Rogers, AR).  Guinea pig complement was 
purchased from Gibco Laboratories (Grand Island, NY). 
Antigens and hnmunizations.  Fluoresceinisothiocyanate (FITC), nitrophenyl (NP), and 
trinitrophenyi (TNP) conjugates were prepared as described (7). The double conjugates 
FITC-KLH-TNP or FITC-BGG-TNP were prepared by incubating 50 mg FITC (Sigma 
Chemical Co., St.  Louis,  MO) and 40  mg trinitrobenzenesulfonic acid (TNBS)  (ICN 
Nutritional Biochemicals, Cleveland, OH) with 100 mg keyhole limpet hemocyanin (KLH) 
(Calbiochem-Behring Corp., San Diego, CA) or 100 mg bovine gamma globulin (BGG) in 
l0 ml of 2% K~COs at room temperature for 2 h, followed by rotation overnight at 4°C 
and  extensive dialysis.  Ficoli  (mol  wt  400,000  Pharmacia,  Inc.,  Piscataway,  NJ)  and 
lipopolysaccharide (LPS) (Escherichia coli 0127:B8; Sigma Chemical Co.) were conjugated 
with E-TNP-L-lysine  (ICN Nutritional Biochemicals)  as described (8). TNP conjugated 
Brucella abortus (B.A.) was prepared as described by Mosier (9). TNP-conjugated polyac- 
rylamide (PAA) was prepared as previously described (10). The synthetic polypeptides L- 
glutamic acid-L-lysine-L-alanine (GLA) and L-glutamic acid-L-lysine-L-tyrosine (GLT) were 
a generous gift of Dr. M. Dorf, Harvard Medical School. 
Mice were primed to TNP-KLH, NP-KLH, or TNP-Bovine serum albumin (BSA) by 
i.p. immunization with 200 ~g antigen in complete Freund's adjuvant. In some cases mice 
were boosted with 100 #g antigen in saline 6-10 wk later. Mice were used 4-8 wk after 
the last immunization. 
Lyt + T Cell Clones.  The derivation and maintenance of the hapten-specific T cell clones 
was described in the preceding paper (7).  • 
Media.  Cells  were cultured in  Dulbecco's modified Eagle's Medium (DME) (Gibco 
Laboratories) supplemented with essential and nonessential amino acids, essential vitamins, 
10% fetal calf serum,  1 mM sodium pyruvate, 2 mM L-glutamine, and 5 ×  10  -5 M 2- 
mercaptoethanol (complete medium). 
Preparation of Supernatants.  Pulsed adherent cells (PAC) were prepared by incubating 
5 x  106 irradiated (2,000R) spleen cells syngeneic with the clone with 100 ~g/ml antigen 
in 24-well tissue culture plates (Linbro, #  76-033-05,  Flow Laboratories, McLean, VA). DEKRUYFF  ET  AL.  1883 
After  2  h,  the  wells  were  washed  with  phosphate-buffered  saline  (PBS)  to  remove 
nonadherent cells (>98%  of the cell population) and excess antigen.  106 CI.Lyl-T1 or 
CI.Lyl-N5 were then added. After 24 h, the supernatants were removed, spun at 1,200 
rpm and stored at -20°C.  In some cases, supernatants were incubated with TNP-BGG 
Sepharose, FITC-BGG Sepharose, or NP-OVA Sepharose (0.5  ml Sepharose/ml super- 
natant)  for 2  h  at  4°C.  After washing,  columns were  eluted  with  0.1  M  ammonium 
hydroxide and neutralized with 0.5 M sodium phosphate. The eluate was then applied to 
a PD 10 column (Pharmacia) and eluted with complete medium. In some cases, superna- 
tants were prepared by incubating 106 CI.Lyt-T1 or CI.Lyl-N5 with 1 ug Con A in  1 ml 
complete medium.  Supernatants  were  harvested  after  24  h  and  10  mg]ml a-methyl- 
mannoside was added. Supernatants were fractionated as described above. 
B Cell Culture.  B plus accessory cells were prepared by sequential positive and negative 
selection. After elution t?om rabbit anti-mouse Fab-coated plates (11), cells were incubated 
with monoclonal (mc) anti-Thy-l.2, anti-Lyl.2, and anti-Ly2.2 plus rabbit complement 
for 45  min  at  37°C  and  washed  with  PBS.  Lack  of residual  T  cells  was  verified  by 
immunofluorescence using anti-Thy-1  antibody, as well as by the  loss of proliferative 
response to Con A and the anti-SRBC piaque-forming cells (PFC) response in vitro. No 
attempts were made. to deplete macrophages from these populations. Accessory cells are 
still present as  judged by the reconstitution of a primary anti-SRBC response with positively 
selected Lyl ÷ T  cells. 
3 x  106 (B plus accessory cells) were incubated in complete medium (1  ml volumes in 
24-well (Linbro) plates) at 37 °C in 10% CO2, and supplemented daily with 0.1 ml medium. 
PFC were enumerated on day 4. Antigen was added at the following concentration: 0.1 
#g/ml hapten-protein antigens, 0.05 ml of a  10% TNP-PAA solution, 0.01  #g/mi TNP- 
ficoll or 5 x  106 SRBC/ml. In some cases, cultures were supplemented with adherent cells 
(macrophages) as described above. 
Incubation of Inducer Molecules with Activated B Cells.  Activated B cells were prepared 
by incubating 7 x  10 7 spleen cells with 0.4% hapten-PAA conjugate in  10 ml complete 
medium in 25-cm  ~ tissue culture flasks (Corning, #25100). After 3 d the viable cells were 
separated on a gradient of Lymphocyte Separation Medium (Litton Bionetics, Kensington, 
MD). These cells were >70% large "blasts." Cells were incubated with the eluate from a 
hapten-Sepharose column (107 B cells/ml eluate) for 1 h at 4  C, centrifuged at 1,200 rpm 
for 10 min and the supernatant was stored at -20°C. 
PFC Assa~,.  PFC  were  determined  by  the Jerne  plaque  technique  as  modified  by 
Dresser anc[ Greaves (12).  TNP-SRBC were prepared as described by Rittenberg and 
Pratt (13).  NP-SRBC were prepared as described by Sherr et al (14).  FITC-SRBC were 
prepared as described by Ramos and Moiler (15). Anti-SRBC PFC were assayed on SRBC. 
In some cases rabbit anti-mouse Ig (Cappel Laboratories, Cochranville, PA) was used to 
develop IgG PFC. All PFC results represent the mean of duplicate or triplicate cultures; 
in all cases the standard error was <10%. 
The  distribution  of affinity  of the  antibody  response  was  determined  by the  PFC 
inhibition procedure of Andersson (16). E-TNP-L-iysine (ICN Pharmaceuticals, Cleveland, 
OH) or NP-caproate (Biosearch, San Rafael, CA) was used to inhibit anti-TNP and anti- 
NP plaques, respectively and was added to both the agarose and the complement where 
indicated. Unless otherwise indicated the number of PFC per culture represent only those 
plaques that were inhibited with 10-'~M TNP-lysine or NP-caproate. 
Results 
Demonstration of Antigen-specific Inducer Activity by a  TNP-spec~c T  Cell 
Clone 
We have generated a series of hapten-specific, Thyl +, Lyl+2-3 -  T  cell clones. 
CI.Lyl-N5  is  activated  only  by  NP-OVA  associated  with  I-A  b  gene  products; 
CI.Lyl-T1  is activated by TNP  coupled to virtually any protein associated with 
I-A  d APC (7). 1884  INDUCER  T  CELL  PRODUCTS 
We asked whether the TNP-specific clone CI.Lyl-T1  might induce purified 
(B plus accessory cells) from mice immune to FITC to secrete anti-FITC antibody. 
Cultures containing CI.Lyl-T1, B cells from donors immune to FITC-BGG, and 
the  double  conjugate  FITC-KLH-TNP  produced  strong  anti-FITC  PFC  re- 
sponses (Fig.  1).  Cultures containing a  mixture of FITC-KLH and TNP-KLH 
did  not  produce  significant  responses  even  when  the  concentration  of each 
conjugate  was  10-100-fold  higher  than  FITC-KLH-TNP  (not shown).  Thus, 
CI.Lyl-T1  induces  B  cells  to  secrete  anti-hapten  antibody  to  hapten-protein 
antigens only if the determinant recognized by the clone (i.e., TNP) is covatently 
coupled to the determinant recognized by immune B cells. 
C1. Lyl-T1 and CI.Lyl-N5 Synthesize Molecules that Mediate Specific Inducer 
Function 
To  obtain  molecules that  mediate  the  activity  of the  intact  inducer  clone, 
supernatants were prepared by incubating CI.Lyl-T1  with either (a) syngeneic 
antigen-pulsed APC or (b) Con A in the absence of other cells. These supernatants 
were applied to hapten-coupled Sepharose 4B columns. The eluate from a TNP- 
Sepharose column was tested for induction of anti-FITC  PFC responses using 
the  assay  described  above.  The  eluate  induced  anti-FITC  PFC  responses  in 
cultures containing the double conjugate FITC-BGG-TNP  but not in cultures 
containing FITCoBGG +  TNP-BGG (Fig. 1). The effluent contained no activity. 
Thus, both the inducer clone as well as products synthesized by the clone activate 
B cells via an antigen bridge. 
We next examined the ability of hapten-reactive inducer cells or their products 
to activate  (B  plus  accessory  cells)  to  produce antibody  to  the  same  hapten. 
CL.  LYI-TI  ANTIGEN IN CULTURE 
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FIGURE  1.  CI.Lyl-T1 and ABM activate B cells via an antigen bridge. Purified B cells were 
prepared from Balb/c mice primed with FITC-BGG (top panel) or FITC-KLH (bottom panel). 
3 ×  10  6 B cells were incubated with 0.1  #g/ml antigen and 3 x  10 4 CI.Lyl-TI cells or 0.1  ml 
ABM derived from CI.Lyl-T1  in a  final volume of 1 m].  PFC shown are the average of 
duplicate cultures, in the absence of hapten inhibitors. DEKRUYFF  ET  AL.  1885 
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FIGURE 2.  Secreted  ABM binds specifically to hapten. 3 x  106 purified B cells from NP- 
KLH-primed  C57BL/6  mice were incubated with 0.1  /~g/ml  NP-OVA.  Supernatant from 
CI.LyI-N5 was fractionated on the indicated column and 0.| ml o£ the eluate or effluent was 
added to the culture. PFC inbibkab]e by  ]0  -~ M  NP-caproate  are shown and represent the 
average of duplicate cultures. *The eluate was centrifuged for 60 min at ]00,000 g before 
addition to cu]tures. 
Supernatants  of the  NP-specific clone CI.Lyl-N5  prepared  as described above 
were applied to Sepharose columns coupled with NP or FITC. The eluate and 
effluent fractions  were tested for induction  of antibody production  by B  cells 
primed to NP-KLH. The eluate from the NP-Sepharose column induced anti- 
NP PFC responses (Fig.  2);  the effluent (representing  "-'95-98%  of internally 
labeled  protein  (data  not  shown))  did  not.  The  eluate  from  the  NP-coupled 
column contained molecules specifically bound to NP but not to another hapten: 
the effluent but not the eluate from a  FITC-coupled column induced an anti- 
NP  PFC  response  2 (Fig.  2).  These  findings  demonstrate  that  (a)  hapten-  or 
antigen-binding molecules (ABM) can induce B cells to produce antibody to the 
same hapten, and (b) since ABM bind to Sepharose coupled with the appropriate 
hapten, NP, but not an inappropriate hapten (FITC), ABM mediate at least part 
of the B cell induction. Additionally, a dose-response curve of inducer activity in 
supernatants  of both  clones  showed  that  (a)  substantial  inducer  activity  was 
demonstrable  even at dilutions  of 1:1,000  (the equivalent  of 104 cloned cells) 
and  (b)  the  activity present  in  the  unfractionated  supernatant  was completely 
recovered in the eluate (Table I). 
Although only IgM PFC were detected in these assays, in all cases 75-80% of 
the anti-TNP  PFC were inhibitable  with  10  -5  M  TNP-lysine.  In contrast,  the 
small numbers of anti-TNP or NP PFC produced in cultures in the absence of 
inducer cells or ABM were not inhibited with  10  -5 M TNP-lysine or NP-caproic 
acid. 
To determine whether ABM are shed or secreted by the clone, the supernatant 
from C1.Lyl-N5 was applied to and eluted from an NP-coupled column and was 
centrifuged for 60 min at  100,000 g. This procedure did not decrease inducer 
2 10-fold more TCA-precipitable CPM of internally labeled peptides bound to the NP-Sepharose 
than to the FITC-Sepharose column (6.25 ×  105 cpm bound to NP Sepharose ("'5% of input cpm) 
vs.  5  ×  104  cpm  to  FITC-Sepharose (<1%  of the  TCA-precipitable cpm) applied)).  The  [s~S]- 
methionine labeled Peptides eluted from NP-Sepharose columns resolved as 4-5 bands ranging from 
25-60 kdahons after sodium dodecyl sulfate-polyacrylamide (12%) gel electrophoresis under reduc- 
ing conditions. 1886  INDUCER  T  CELL  PRODUCTS 
TABLE  I 
Titration of Inducer Activity Produced by CI.Lyl-T1 and CI.Lyl-N5* 
Addition to culture 
PFC/Culture 




1:10  2,160  1,050 
1:100  945  690 
1 : 1,000  675  180 
1 : 10  2,790  950 
1:100  990  620 
1:1,000  720  210 
1:10  205  45 
1:100  135  35 
1 : 1,000  135  27 
* 3 X  106 purified B cells from NP-KLH primed C57BL/6 (Expt.  1) or TNPoKLH primed BALB/c 
(Expt. 2) mice were incubated with 0.1  #g/ml NP-OVA or TNP-BGG, respectively. Supernatant 
from  CI.LyI-N5  (Expt.  1) or  C1.Lyl-T1  (Expt.  2)  was  fractionated on  NP-Sepharose or  TNP- 
Sepharose, and added to cultures at the indicated concentration. Anti-NP (Expt.  1) or anti-TNP 
(Expt.  2)  PFC  were assayed after  4  d.  PFC  inhibitable by  10  -s M  NP-caproate or TNP-lysine, 
respectively, are shown and represent the average of duplicate cultures. 
activity in  the  eluate  (Fig.  2),  suggesting that  inducer activity  is  mediated by 
secreted ABM rather  than  mediated by fragments of cell membranes or lipo- 
somes. 
Evidence that ABM Represent a Secreted Form of the Cell Surface Receptor 
H-2 restriction of  specific inducer activity by ABM.  To determine whether inducer 
activity mediated by ABM is restricted to B cells/macrophages sharing the same 
H-2 genes, the eluate fraction of supernatant from clone C1.Lyl-T1  (H-2 d) was 
added to cultures containing purified (B plus accessory cells) from either TNP- 
KLH-primed BALB/c or C57BL/6  mice and irradiated  CB6FI  adherent cells 
from unprimed mice. The eluate induced BALB/c but not C57BL/6 B cells to 
produce strong anti-TNP PFC responses (Fig. 3). 
To map this restriction more precisely, the eluate prepared from clone C1.Lyl- 
N5(H-2 b) was added to purified (B plus accessory cells) from NP-KLH-primed 
B10 (H-2 b) or B10.A (4R) (H-2 h4) mice, which differ only at the H-2K and I-A 
loci. A substantial anti-NP response was induced in cultures containing B10 but 
not B10.A (4R) (B plus accessory) cells. 
The above  experiments  show  that  anti-hapten  responses  to  hapten-protein 
conjugates were obtained only when inducer ABM were incubated with B cells 
(and possibly macrophages) identical at the I-A locus (Fig. 3). One explanation 
for this observation is that the secreted ABM represents a modified form of the 
cell-bound receptor and, like the inducer ceil, recognizes I-A gene products in 
association with antigen. To directly test this hypothesis, ABM were incubated 
with syngeneic or ailogeneic B cells and then assayed for antigen-specific inducer 
activity. Incubation with activated B cells from allogeneic strains had no effect 
on subsequent inducer activity; in contrast, incubation with strains identical at 
the I-A region (e.g., B6 vs. B10A.4R) resulted in the complete loss of inducer 
activity (Table II). In experiments not shown we found that ABM inducer activity 
was also depleted after incubation with unactivated syngeneic, but not allogeneic DEKRUYFF  ET  AL.  1887 
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FIGURE 3.  Specific inducer activity of ABM is H-2 restricted.  Upper panel: 3 x  l0  s purified 
B cells from TNP-KLH primed mice were incubated with 0.1 ,g/ml TNP-BGG. Supernatant 
from CI.Ly 1-T 1 was fractionated on TNP-Sepharose and 0.1 ml eluate added to the cultures. 
Where indicated,  cultures were supplemented with irradiated adherent cells from unprimed 
CB6F1 mice. After 4 d cultures were assayed for anti-TNP PFC. Lower panel: 3 X 106 purified 
B cells from NP-KLH-primed mice were incubated with 0.1  tzg]ml NP-OVA.  Supernatant 
from CI.LyI-N5 was fractionated on NP-Sepharose and 0.1 ml eluate added to the cultures. 
After 4 d cultures were assayed for anti-NP PFC. PFC inhibitable by 10  -5 M TNP-lysine or 
NP-caproate,  respectively, are shown and represent the average of duplicate cultures. 
TABLE  II 
Loss of Inducer Activity Following Preincubation of ABM with Syngeneic Activated B Cells 
Source of activated 
Source of ABM*  B cells used for  PFC/Culture  i 
preincubation* 
Expt. 1  C1.Lyl-TI (BALB/c origin)  a, None  1,350 
b, C57BL/6  1,420 
c, A]J  1,310 
d, BALB/c  190 
e, b + d I  1,375 
Expt. 2  C1.LyI-N5 (C57BL/6 origin)  None  860 
C57BL/6  0 
B 10.A (4R)  840 
* Supernatants prepared from CI.Lyl-T1 (Expt. 1) or CI.Lyl-N5 (Expt. 2) were fractionated on NP- 
Sepharose or TNP-Sepharose to obtain ABM. 
* Where indicated,  the ABM was preincubated with activated  B cells (see Materials and Methods) 
before addition to cultures. 
3 x  106 purified B cells from TNP-KLH primed BALB]c (Expt. 1) or NP-KLH primed C57BL/6 
(Expt. 2) mice were incubated  with 0.1 tzg/ml TNP-BGG or NP-OVA respectively, and the indicated 
ABM. After 4 d, cultures were assayed for anti-TNP (Expt. 1) or anti-NP (Expt. 2) PFC. 
!  A mixture of supernatants incubated with activated B cells from group b (C57BL/6) and group d 
(BALB/c) were  tested  for inducer activity to rule out the possibility that after incubation with 
syngeneic B cells (group d) supernatants did not acquire suppressive activity. 
B  cells.  However,  removal  of inducer activity was  incomplete, implying that 
activated B  cells express  more surface  I-A than do resting B  cells.  This result 
does not bear on whether the secreted ABM is composed of two separate proteins 
that bind to antigen and to I-A, respectively, or one that binds both. However, 
collectively these  experiments show  that  activation of  B  cells  is  mediated  by 1888  INDUCER  T  CELL  PRODUCTS 
secreted inducer molecules that recognize both antigen and I-A products on B 
cells. 
Fine specificity of B cell activation by ABM.  CI.Lyl-T1 is activated by autologous 
or foreign proteins such as the synthetic polymer TNP-GLA that are restricted 
by  I-A  d  gene  products  (e.g.  TNP-GLA).  In  contrast,  TNP  coupled  to  I-E 
controlled polymers (such as GLT)  (25)  does not activate C1.Lyl-T1  (7).  We 
reasoned that if ABM secreted by CI.Lyl-T1 represents a secreted form of the 
receptor,  then  ABM  might  display  the  same fine  specificity as  the  receptor. 
Failure of ABM to recognize and bind to TNP-GLT/I-A complexes on B cells 
might prevent delivery of the inducer signal to the target B cell. This was the 
case (Fig. 4):  incubation of TNP-primed B cells with ABM and TNP-GLA but 
not TNP-GLT elicited strong anti-TNP responses. 
These  findings  show  that  secreted  inducer  molecule(s)  that  activate  PFC 
responses co-recognize I-A and antigen on B cells with the same fine specificity 
as  the  cell-bound  receptor.  The  most  parsimonious  interpretation  of  these 
observations is that ABM represents a secreted product of the same gene(s) that 
encode the T  cell receptor. 
Separation of Antigen-specific from Nonspecific Helper Factors 
Although antigen-specific B  cell activation  by CI.Lyl-T1  and  C1.Lyl-N5  is 
mediated by molecules that co-recognize antigen and I-A displayed on B cells 
(Figs.  2-4),  these  clones  also  produce  factors  that  induce  B  cell  responses 
independent of an antigen bridge (nonspecific help). We attempted to separate 
the inducer cell products responsible for the two functions. Supernatants from 
antigen-stimulated CI.Ly 1-T 1 were applied to TNP-coupled Sepharose columns. 
The eluate, effluent, and unfractionated supernatant were tested for nonspecific 
and specific inducer activity (Fig.  5).  Unfractionated supernatant as well as the 
eluate from the TNP-Sepharose column stimulated the production of antioTNP 
PFC  by  B  cells  from  mice immune to  TNP-KLH  while  the effluent did  not 
induce a significant anti-TNP PFC response at any concentration tested. More- 
over, neither the whole supernatant nor the TNP-column eluate induced B cells 
from mice primed to  FITC-KLH  to  respond to  FITC-BGG,  confirming and 
extending earlier results indicating the specificity of B cell activation by ABM 
(Figs.  2 and 3). 
These data also show that  the  unfractionated supernatant  induces virgin B 
cells to generate anti-SRBC PFC.  However, in contrast to induction of hapten- 
ANTIGEN IN CULTURE  ANTI-TNP PFC/CULTURE (x I0  "z) 
TNP- BGG  ;~ 
TNP-GLA 
TNP-  BGG * TNP-GLA 
TNP-GLT 
2  4  6  8 
FIGURE 4.  Fine specificity of B cell activation by ABM. 3 x  106 purified B cells from TNP- 
KLH-primed BALB/c mice  were incubated with  0.1  /~g/ml  antigen and  0.1  ml  of ABM 
derived from CI.Ly 1-T 1. In the absence of el  uate, there were 50 PFC/culture. PFC inhibitable 
by l0  -'~ M TNP-lysine are shown and represent the average of duplicate cultures. The results 
from one of two similar experiments is shown. DEKRUYFF  ET  AL. 
B-cells from 
donors immulw Io=  FITC -  KLH  TNP- KL.H  None 
Anti~len in culture=  FITC -  BGG  TNP  - BGG  SRBC 
1889 
Eluote  ~ml 
FIowthrough 
I0  20  I0  20  15  50 
PFC/Culture  (x 10 -2) 
FIGURE 5.  A single helper cell produces antigen-specific  and nonspecific molecules. Purified 
B cells were prepared from BALB/c mice which had been primed as indicated. 3 ×  10  6 cells 
were incubated with 0.1  pg/ml FITC-BGG, TNP-BGG or 5 x  10  6 SRBC/ml, and 0.1  ml of 
the supernatant, eluate or effluent from CI.Lyl-T 1 as indicated. The results from one of three 
similar experiments are shown. 
specific PFC responses, the inducer activity resided in the column effluent. Thus, 
a  single  helper  cell  produces  both  antigen-specific  and  nonspecific  inducer 
molecules; the two can be separated on  Sepharose columns coupled with  the 
appropriate antigen. 
Clone Supernatants Enhance B Cell Responses to Type 2 T-independent 
Antigens 
Responses  to  the  Type  1  T-independent  antigens  TNP-lipopolysaccharide 
(TNP-LPS) and TNP-Brucella abortus (TNP-BA) appear to be independent of T 
cells.  However,  recent studies  have  shown  that  responses  to  the  Type  2  T- 
independent antigens TNP-polyacrylamide (TNP-PAA) and TNP-ficoll are in 
fact dependent on T  cells or their products (1, 2). We therefore asked whether 
CI.Lyl-T1 or C1.Lyl-N5 inducer cell products might induce B cells to respond 
to Type 1 or 2 T-independent antigens. Purified B cells (and macrophages) from 
unprimed mice were incubated with different T-independent antigens (Table 
I I I). Addition of unfractionated clone supernatant greatly increased the response 
to TNP-PAA and TNP-ficoll (Type 2 antigens), but had no effect on the response 
to TNP-LPS or TNP-BA (Type I antigens).  Induction was due to nonspecific 
factors rather than  to  TNP-specific ARM  because (a) whole supernatants  en- 
hanced the response to FITC-PAA (Table III), (b) the effluent rather than the 
eluate fraction from TNP Sepharose columns contained inducer activity, and (c) 
supernatants of C1.Lyl-N5 (H-2  b) and C1.Lyl-T1  (H-2  d) were equally effective 
in  augmenting an anti-TNP-PAA  response of H-2  d B  cells, indicating lack of 
MHC restriction. 
Discussion 
These studies show that hapten-specific inducer clones produce soluble factors 
that activate B cells to secrete antibody. Cells of a single inducer clone produce 
two types of inducer molecules: antigen-specific molecules (ARM) that induce 
responses to hapten-protein conjugates and nonspecific molecules. The latter do 
not require Ia homology between the strain of origin of the inducer cell and B 
cells to induce antibodies to SRBC and Type 2 T-independent antigens. These 1890  INDUCER  T  CELL  PRODUCTS 
TABLE  III 
Nonspecific Factors Produced by Activated Clones Facilitate a B Cell Response to Type 2 
T-independent Antigens 
Antigen in culture*  Supernatant*  PFC/culture  ! 
TNP-LPS  -  4,020 
+  3,920 
TNP-B.A.  -  3,260 
+  3,240 
TNP-PAA  -  520 
+  9,120 
TNP-Ficol]  -  185 
+  1,720 
FITC-PAA  Unfractionated  5,126 
Eluate  480 
Effluent  4,880 
* 3 x  106 purified B cells were prepared from virgin BALB/c mice and incubated with 0.01 tzg/ml 
TNP-LPS, 109 TNP-B.A. organisms, 0.5% hapten-PAA, or 0.01 #g/ml TNP-ficoll. 
* Unfractionated supernatant derived from CI.Lyl-T1 was added to the cultures, with the exception 
of cultures containing FITC-PAA in which case the supernatant was fractionated on a TNP- 
Sepharose column. In all cases, supernatant or fractions were added at a final concentration of 
10%. 
0 After 4 d of culture, anti-TNP or anti-FITC PFC were assayed in the absence of inhibitors. One 
of six similar experiments is shown. 
clones also synthesize and secrete factors that bind to antigen (ABM) and activate 
only those B cells that are (a) linked to the antigen via a bridge and (b) syngeneic 
with the inducer clone at I-A (H-2 restriction). We show that this phenomenon, 
"antigen-specific, H-2-restricted" help, reflects binding of ABM to both I-A and 
antigen on the B cell surface. 
These studies explain, in part, the failure despite extensive effort to identify 
inducer molecules that mediate the activity of the intact ceil. There are several 
reasons  for  this.  First,  considerably  higher  concentrations  of antigen-specific 
peptides may be synthesized by homogeneous populations (clones) of T  cells than 
by heterogeneous populations or by T  cells that have been fused with tumors. 
Second, both antigen-specific and nonspecific factors are synthesized solely by 
the T  cell clones because both are produced after activation either by antigen- 
pulsed APC  or by Con A  in  the absence  of other cell  types.  It is essential to 
separate  nonspecific  helper  factors  from  ABM  on  antigen-coupled  columns 
before assay because antigen-specific inducer activity is normally masked by the 
nonspecific factors produced after clonal activation. 
Previous studies demonstrated that supernatants from T  cell hybridomas can 
augment in vitro PFC responses of cultures containing both T  and B cells (17, 
18).  This  augmenting  activity  is  lost  after  passage  of supernatants  through 
columns conjugated with (a) anti-I-A (17,  18),  (b)  antiidiotype (17),  (c) anti-VH 
(17,  18), and (d) antigen (17,  18).  In all cases biologic activity was measured by 
PFC generated from spleen cells rather than purified B  cells: the augmenting 
activity of these factors may reflect an effect on T  cells rather than a direct effect 
on  B  cells.  There  is a  single report  suggesting that factors from T  cell clones 
specific for horse erythrocytes bind specifically to erythrocytes and  "prepare" 
small B cells to make antibody after a  second encounter with B cell replication DEKRUYFF  ET  AL.  1891 
and maturation factors (19). However, this study and others show that activated 
Lyl + T  cells produce nonspecific lymphokines that are sufficient to  stimulate 
division and  production of anti-SRBC  PFC  by cultures containing purified  B 
cells and macrophages (3-5). 
ABM present in  the eluate from hapten-coupled Sepharose columns induce 
anti-hapten  PFC  responses  to  hapten-protein  conjugates  but  do  not  activate 
responses to SRBC or Type 2 antigens. B cell growth factors have been shown 
to be required for the latter responses (1-5) and may well be involved in the 
former.  Perhaps enough of this  material  is  complexed with the ABM  and  is 
efficiently targeted to the appropriate B cell. Preliminary results show that some 
BCGF activity is present in  column eluates but at much lower concentrations 
than in the effluent (data not shown). 
The concept ofa hapten-specific helper T cell is relatively recent. The majority 
of T  cells recognize protein carriers, whereas B cells can produce antibody to 
either hapten or protein determinants. The findings reported here emphasize 
that there is no functional division of labor based on specificity for protein and 
haptenic determinants. This is most directly shown by our demonstration that a 
hapten can "help" itself.  Previous failures to demonstrate hapten-specific help 
probably reflect the predominance of inducer clones that recognize hapten only 
in association with a unique amino acid sequence on the carrier protein (7). 
Hapten-specific helper activity mediated by ABM  is H-2 restricted since (a) 
help is restricted to B cells that share I-A identity and (b) help can be depleted 
by incubation of inducer ABM on syngeneic but not allogeneic activated B cells. 
It  is  therefore  of interest  that  ABM  activity  is  retained  on  hapten-coupled 
Sepharose columns that lack I-A. Possibly, multiple epitopes stabilized on a solid 
surface provide a  sufficient matrix for low affinity binding in  the absence of 
MHC products. Alternatively, it is possible that MHC products are carried over 
from the cell culture. 
We used the double hapten conjugate FITC-KLH-TNP to show that significant 
antibody  responses  require  targeting  of the  cloned  cells  (C1.Lyl-T1)  or  its 
product(s) to the B cell by an antigen bridge, despite the fact that IgM and not 
IgG PFC were induced. Roehm et al. (20),  who measured only IgM PFC, also 
demonstrated a  requirement for linked recognition in cultures containing low 
doses of antigen and an antigen-specific T  cell hybridoma. This is in contrast to 
the findings of Asano et al. (6). Their results suggest that Lyb5- B cells require 
linked recognition as well as H-2 identity between B cells, T  cells, and macro- 
phages to produce IgG. In contrast, Lyb5  + B cells produce IgM in the absence 
of an antigen bridge, although high doses of antigen are required. 
The above data may be reconciled if B cells (e.g. Lyb5-) that require linked 
recognition and MHC identity fail to switch to IgG production in the absence of 
factors provided by a second T  cell. Limiting dilution studies of Rosenberg and 
Asofsky (21) suggest that while one type of helper cell is sufficient for an IgM 
PFC response in vitro, two are needed for an IgG response (21).  Isakson et al. 
(22) have shown that some T  cell lines or hybridomas produce factors that are 
capable of mediating an IgM to IgG transition in vitro (22). We have isolated a 
clone that is reactive to autologous I-A on activated B cells (Clayberger, C., R. 
H.  DeKruyff, and H. Cantor, manuscript submitted). The cell, or its products, 1892  INDUCER T  CELL PRODUCTS 
stimulate an IgM to IgG switch in the in vitro system described here as well as 
in other in vivo and in vitro systems. For example, addition of this clone or its 
products  to  cultures containing ABM  and  hapten-primed B  cells  results  in  a 
strong  IgG  response.  This  type of cell  may be  particularly important  in  the 
response to antigens containing repeating epitopes (e.g. highly conjugated TNP- 
BGG) to which an IgG response is not as readily obtained (23). 
After activation, CI.Lyl-T1 and C1.Lyl-N5 also produce antigen nonspecific, 
H-2-restricted  factors that promote B  cell responses to  SRBC  or Type 2  T- 
independent  antigens.  Responses  to  both  antigens  depend  on  factors  from 
activated T  cells and/or macrophages, which may include interleukin 1, interleu- 
kin 2, and B cell growth factors (5).  Addition of factors from activated macro- 
phages alone had no effect on the anti-SRBC or Type 2 responses studied here 
(data not shown), presumably because preparations contained sufficient numbers 
of macrophages; all nonmacrophage factors necessary for activation of these PFC 
responses were provided by T  cell clones. 
The finding that ABM inducer activity in the supernatant is not diminished 
after ultracentrifugation (100,000 g  for  1 h) suggests that  ABM are secreted 
products of inducer cells. In principle cytoplasmic proteins released from dead 
cells may remain in the supernatant after centrifugation. However, ABM activitry 
is highest early after activation of the clones (24),  when cell viability is highest 
(>95%).  Experiments to demonstrate that ABM are secreted, rather than shed 
or released, are currently in progress. 
The data reported here thus strongly support the view that ABM represent a 
modified, secreted form of the cell surface receptor.  If the fine specificity of 
activation of CI.Lyl-T1  is determined by a  cell-bound receptor, then this rec- 
ognition structure has the following three properties:  (a) it distinguishes com- 
pletely between TNP  and  FITC,  (b)  it  recognizes a  portion of the  I-A  gene 
product, and (c) it does not recognize TNP conjugated to I-E-controlled poly- 
mers such as GLT (25),  but responds well to TNP coupled to  I-A-controlled 
polymers such as GLA. The specificity of ABM activation of B cells displays these 
features: (a) ABM binds to TNP-Sepharose and not FITC-Sepharose columns. 
(b) inducer activity is lost after incubation with B cells expressing the I-A genotype 
identical  to  that of the clone, and (c) ABM  from CI.Lyl-T1  activates  B  cells 
cultured with TNP-GLA but fails to stimulate B cells cultured with TNP-GLT. 
Thus, ABM are characterized by properties analogous to those displayed by the 
cell-bound receptor and most likely represent a modified form of this structure. 
Taken together, these findings indicate that at least some antibody responses 
to  proteins  may not  depend on  cognate B  cell-T cell  interaction.  Instead,  a 
secreted form  of the  inducer  T  cell  receptor  induces antibody  secretion  by 
antigen-specific, I-A identical B  cells.  The fine specificity of secreted inducer 
molecules, as defined here, ensures that B cell clones activated by secreted ABM 
belong to the same pool as those triggered by the intact inducer cell. 
Summary 
The biologic activity of molecules synthesized and secreted by hapten-specific 
inducer T  cells was examined. After activation, a single inducer clone secretes 
both antigen-specific inducer peptides as well as nonspecific factors. The nonspe- DEKRUYFF  ET  AL.  1893 
cific factors augment the in vitro response of B cells to sheep erythrocytes (SRBC) 
and  Type  2  T-independent  antigens.  The  antigen-specific  molecules  (ABM) 
induce plaque-forming cell (PFC) responses in cultures containing ABM, B cells, 
and antigen that links the epitope recognized by ABM with the B cell epitope. 
Induction of B cells by ABM is limited to B cells expressing the same I-A allele 
as the source of the ABM and this reflects binding by ABM to I-A products on 
B lympbocytes. The data reported here strongly support the view that inducer 
cells can activate at least some B cells by secretion of a  modified form of the T 
cell surface receptor. 
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